Systems and methods for intravascular catheter positioning and/or nerve stimulation

Information

  • Patent Grant
  • 10039920
  • Patent Number
    10,039,920
  • Date Filed
    Thursday, September 14, 2017
    7 years ago
  • Date Issued
    Tuesday, August 7, 2018
    6 years ago
Abstract
A method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of electrodes, and multiple electrodes of the plurality of electrodes are configured to emit electrical signals; positioning a distal portion of the catheter in a first position; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on the acquired ECG signal, adjusting the distal portion of the catheter to a second position different from the first position; identifying at least one first electrode of the plurality of electrodes to stimulate a first nerve; identifying at least one second electrode of the plurality of electrodes to stimulate a second nerve; and stimulating at least one of the first and second nerves to cause a contraction of a respiratory muscle.
Description
TECHNICAL FIELD

This disclosure relates to systems, devices, and methods for one or more of positioning an intravascular nerve stimulation catheter, selecting electrodes for nerve stimulation, or stimulating nerves.


BACKGROUND

Electrical stimulation of nerves may be used to control muscle activity or to generate or attenuate sensations. Nerves and muscles may be stimulated by placing electrodes in, around, or near the nerves and muscles and by activating the electrodes by means of an implanted or external source of energy (e.g., electricity).


The diaphragm muscle provides an important function for the respiration of human beings. The phrenic nerves normally transmit signals from the brain to cause the contractions of the diaphragm muscle necessary for breathing. However, various conditions can prevent appropriate signals from being delivered to the phrenic nerves. These include: permanent or temporary injury or disease affecting the spinal cord or brain stem; Amyotrophic Lateral Sclerosis (ALS); decreased day or night ventilatory drive (e.g., central sleep apnea, Ondine's curse); and decreased ventilatory drive while under the influence of anesthetic agents and/or mechanical ventilation. These conditions affect a significant number of people.


Intubation and positive pressure mechanical ventilation (MV) may be used for periods of several hours or several days, sometimes weeks, to help critically ill patients breathe while in intensive care units (ICU). Some patients may be unable to regain voluntary breathing and thus require prolonged or permanent mechanical ventilation. Although mechanical ventilation can be initially lifesaving, it has a range of significant problems and/or side effects. Mechanical ventilation:

    • often causes ventilator-induced lung injury (VILI) and alveolar damage, which can lead to accumulation of fluid in the lungs and increased susceptibility to infection (ventilator-associated pneumonia, VAP);
    • commonly requires sedation to reduce discomfort and anxiety in acutely intubated patients;
    • leads to rapid atrophy of the disused diaphragm muscle (ventilator-induced diaphragm dysfunction, VIDD);
    • can adversely affect venous return because the lungs are pressurized and the diaphragm is inactive;
    • interferes with eating and speaking;
    • requires apparatus that is not readily portable; and
    • increases the risk of dying if the patient fails to regain normal breathing and becomes ventilator-dependent.


A patient who is sedated and connected to a mechanical ventilator cannot breathe normally because the central neural drive to the diaphragm and accessory respiratory muscles are suppressed. Inactivity leads to muscle disuse atrophy and an overall decline in well-being. Diaphragm muscle atrophy occurs rapidly and can be a serious problem to the patient. According to a published study of organ donor patients (Levine et al., New England Journal of Medicine, 358: 1327-1335, 2008), after only 18 to 69 hours of mechanical ventilation, all diaphragm muscle fibers had shrunk on average by 52-57%. Muscle fiber atrophy results in muscle weakness and increased fatigability. Therefore, ventilator-induced diaphragm atrophy could cause a patient to become ventilator-dependent. It has been estimated that over 600,000 U.S. patients will be ventilator-dependent and require prolonged mechanical ventilation by the year 2020. Zilberberg et al., “Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery,” Crit Care Med., 2008 May, 36(5): 1451-55.


SUMMARY

Embodiments of the present disclosure relate to, among other things, systems, devices, and methods for one or more of positioning an intravascular nerve stimulation catheter, selecting electrodes for nerve stimulation, or stimulating nerves. Each of the embodiments disclosed herein may include one or more of the features described in connection with any of the other disclosed embodiments.


In one example, a method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of electrodes, and multiple electrodes of the plurality of electrodes are configured to emit electrical signals; positioning a distal portion of the catheter in a first position; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on the acquired ECG signal, adjusting the distal portion of the catheter to a second position different from the first position; identifying at least one first electrode of the plurality of electrodes to stimulate a first nerve; identifying at least one second electrode of the plurality of electrodes to stimulate a second nerve; and stimulating at least one of the first and second nerves to cause a contraction of a respiratory muscle.


Any method described herein may additionally or alternatively include one or more of the following features or steps: inserting the intravascular catheter into the venous system may include inserting the intravascular catheter into: 1) at least one of a left subclavian, axillary, cephalic, cardiophrenic, brachial, radial, or left jugular vein, and 2) a superior vena cava; the first position may be proximate an atrium of a heart of the patient, and the second position may be in a superior vena cava; the ECG signal may be a first ECG signal, and the method may further comprise using one or more electrodes of the plurality of electrodes to acquire a second ECG signal; the one or more electrodes used to acquire the first ECG signal may be positioned on a proximal portion of the catheter and may be configured to stimulate the first nerve, and the one or more electrodes used to acquire the second ECG signal may be positioned on a distal portion of the catheter and may be configured to stimulate the second nerve; the method may further include comparing the first ECG signal to the second ECG signal, and based on the comparison, adjusting the distal portion of the catheter to the second position; the second position may be farther from a heart of the patient than the first position; the method may further include using one or more electrodes of the plurality of electrodes to sense at least one of an impedance or nerve activity; or each of the at least one first electrode and the at least one second electrode may be a combination of electrodes.


In another example, a method for positioning an intravascular catheter may include inserting the intravascular catheter into: 1) at least one of a left subclavian vein or a left jugular vein, and 2) a superior vena cava, wherein the catheter includes a plurality of electrodes, and the plurality of electrodes includes a proximal set of electrodes positioned proximate a left phrenic nerve and a distal set of electrodes positioned proximate a right phrenic nerve; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on a change in the ECG signal, withdrawing the catheter away from a heart of a patient; stimulating the left phrenic nerve using one or more electrodes of the proximal set of electrodes; and stimulating the right phrenic nerve using one or more electrodes of the distal set of electrodes.


Any method described herein may additionally or alternatively include one or more of the following features or steps: the change in the ECG signal may be a change in an amplitude of a P-wave, and the change may occur as a distal end of the catheter enters a region proximate an atrium of the heart; the step of withdrawing the catheter away from the heart may cause a change in the amplitude of the P-wave; the ECG signal may be a first ECG signal acquired by one or more electrodes of the proximal set of electrodes, and the method may further include using one or more electrodes of the distal set of electrodes to acquire a second ECG signal; the method may further include determining a difference between a P-wave of the first ECG signal and a P-wave of the second ECG signal, and withdrawing the catheter away from the heart of the patient when the difference exceeds a predetermined value; the difference may exceed the predetermined value when the catheter is advanced into an atrium of the heart; a hub coupled to the catheter and positioned exterior to the patient may be used with the one or more electrodes of the plurality of electrodes to acquire the ECG signal; or the method may further include monitoring the ECG signal as a distal end of the catheter is inserted into the at least one of the left subclavian vein or the left jugular vein and advanced into the superior vena cava.


In yet another example, a method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of proximal electrodes and a plurality of distal electrodes; using one or more electrodes of the plurality of proximal electrodes to acquire a first ECG signal, and using one or more electrodes of the plurality of distal electrodes to acquire a second ECG signal; comparing the first ECG signal to the second ECG signal; based on the comparison between the first ECG signal and the second ECG signal, adjusting a position of the catheter; stimulating the first nerve using one or more of the plurality of proximal electrodes; and stimulating the second nerve using one or more of the plurality of distal electrodes.


Any method described herein may additionally or alternatively include one or more of the following features or steps: the first nerve may be a left phrenic nerve, and the second nerve may be a right phrenic nerve; comparing the first ECG signal to the second ECG signal may include comparing an amplitude of a portion of the first ECG signal to an amplitude of a portion of the second ECG signal; the step of comparing may occur a plurality of times during the inserting step; adjusting the position of the catheter may include moving the catheter away from a heart; at least one of stimulating the first nerve or stimulating the second nerve may cause a contraction of a diaphragm; or the method may further include sensing activity of the first nerve using one or more of the proximal electrodes and sensing activity of the second nerve using one or more of the distal electrodes


In another example, a method for positioning an intravascular catheter may include inserting the intravascular catheter into: 1) at least one of a left subclavian vein or a left jugular vein, and 2) a superior vena cava, wherein the catheter includes a plurality of proximal electrodes configured to be positioned proximate a left phrenic nerve and a plurality of distal electrodes configured to be positioned proximate a right phrenic nerve; at multiple positions of the catheter during the inserting step, using one or more electrodes of the plurality of proximal electrodes to acquire a first ECG signal, and using one or more electrodes of the plurality of distal electrodes to acquire a second ECG signal; comparing the first ECG signal to the second ECG signal at several of the multiple positions; based on the comparisons of the first ECG signal to the second ECG signal, determining a desired position of the catheter for nerve stimulation; stimulating the left phrenic nerve using one or more of the plurality of proximal electrodes; and stimulating the right phrenic nerve using one of more of the plurality of distal electrodes.


Any method described herein may additionally or alternatively include one or more of the following features or steps: the method may further include advancing a distal end of the catheter into a region proximate an atrium of a heart; one of the multiple positions may be a position in which the distal end of the catheter is proximate the atrium of the heart, and in the position, the comparison may indicate a difference between an amplitude of the first ECG signal and an amplitude of the second ECG signal that exceeds a predetermined value; the method may further include moving the catheter away from the heart; stimulating the left phrenic nerve may cause a diaphragm contraction, and stimulating the right phrenic nerve may cause a diaphragm contraction; the proximal electrodes used to acquire the first ECG signal may be configured to stimulate the left phrenic nerve, and the distal electrodes used to acquire the second ECG signal may be configured to stimulate the right phrenic nerve.


It may be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed. As used herein, the terms “comprises,” “comprising,” or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. The term “exemplary” is used in the sense of “example,” rather than “ideal.”





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate exemplary embodiments of the present disclosure and together with the description, serve to explain the principles of the disclosure.



FIG. 1 illustrates a nerve stimulation system with an intravascular catheter positioned within a patient, according to an exemplary embodiment.



FIG. 2 illustrates a nerve stimulation system having a portable control unit, according to an exemplary embodiment.



FIG. 3 illustrates a wireless configuration of a nerve stimulation system, according to an exemplary embodiment.



FIG. 4 illustrates an intravascular catheter having a helical portion, according to an exemplary embodiment.



FIG. 5 illustrates an intravascular catheter having an optical fiber camera, according to an exemplary embodiment.



FIG. 6 illustrates an intravascular catheter having an ultrasound transducer, according to an exemplary embodiment.



FIG. 7 illustrates a block diagram of a nerve stimulation system having an intravascular catheter and a control unit, according to an exemplary embodiment.





DETAILED DESCRIPTION

When electrically stimulating nerves or muscles, a variety of goals may be considered. First, it may be desirable to place the electrodes in proximity to the phrenic nerves. Second, it may be desirable to avoid placing electrodes in close proximity to the sinoatrial (SA) node, atrioventricular (AV) node, or the His-Purkinje system located in heart tissue, as electrical stimulation of these anatomical features may cause arrhythmia. Third, when using a device that includes multiple electrodes, it may be desirable to identify particular electrodes that are in close proximity to the nerve. Identifying the proper electrodes may minimize the electrical charge required to effectively stimulate the nerves. Finally, as with any medical procedure, the risk of injury to the patient increases with the length and complexity of the medical procedure. Accordingly, it may be desirable to minimize the length of any procedure to electrically stimulate nerves or muscles.


There remains a need for cost-effective, practical, surgically simple, and minimally invasive devices and methods that address one or more of the above goals and can include one or more of a variety of functions, including: determining whether a nerve is the target nerve, stimulating breathing, delivering treatment (e.g., medications), sensing electrical signals from the body (e.g., ECG), sensing internal vascular blood pressure, heart rate, and electrical impedance, and performing tests, such as detecting respiration rate and blood gas levels (e.g, CO2, O2). There is also a need for devices and methods to help patients wean from mechanical ventilation and regain the ability to breathe naturally.


Accordingly, the present disclosure is drawn to systems, devices, and methods for one or more of positioning an intravascular catheter for nerve stimulation, selecting electrodes for nerve stimulation, and stimulating nerves. In particular, embodiments of the present disclosure may use various positioning features to obtain information useful for positioning a transvascular nerve stimulation catheter, or may use information gathered by sensors to select electrodes and parameters for nerve stimulation.


General System Overview



FIG. 1 illustrates a system 10 that includes a transvascular nerve stimulation catheter 12 and a control unit 14. Catheter 12 may include a plurality of electrodes 34. Catheter 12 may be operably connected (e.g., hardwired, wireless, etc.) to a control unit 14. The control unit 14 may be programmed to perform any of the functions described herein in connection with system 10. In some embodiments, the control unit 14 may include a remote controller 16 to allow a patient or health professional to control operation of the control unit 14 at a distance from the control unit 14. The controller 16 may include a handheld device, as illustrated in FIG. 1. In some examples, controller 16 may include a footswitch/pedal, a voice-activated, touch-activated, or pressure-activated switch, or any other form of a remote actuator. The control unit 14 may include a touch screen 18 and may be supported by a cart 20.


During use, a proximal portion of catheter 12 may be positioned in a left subclavian vein 22, and a distal portion of catheter 12 may be positioned in a superior vena cava 24. Positioned in this manner, electrodes 34 on the proximal portion of catheter 12 may be positioned proximate a left phrenic nerve 26, and electrodes 34 on the distal portion of catheter 12 may be positioned proximate a right phrenic nerve 28. Left and right phrenic nerves 26, 28 may innervate a diaphragm 30. Accordingly, catheter 12 may be positioned to electrically stimulate one or both of the left and right phrenic nerves 26, 28 to cause contraction of the diaphragm muscle 30 to initiate or support a patient breath. In other embodiments, the proximal portion of catheter 12 may be positioned in a left jugular vein 32, and the distal portion of catheter 12 may be positioned in superior vena cava 24.


In further examples, catheter 12 can be placed into and advanced through other vessels providing access to the locations adjacent the target nerve(s) (e.g., phrenic nerves), such as: the jugular, axillary, cephalic, cardiophrenic, brachial, or radial veins. In addition, catheter 12 may use other forms of stimulation energy, such as ultrasound, to activate the target nerves. In some examples, the system 10 can target other respiratory muscles (e.g., intercostal) either in addition to, or alternatively to, the diaphragm 30. The energy can be delivered via one or more methods including transvascular, subcutaneous, nerve cuffs, transdermal stimulation, or other techniques known in the field.



FIG. 2 illustrates an alternative example of system 10, in which control unit 14′ is portable. Portable control unit 14′ may include all of the functionality of control unit 14 of FIG. 1, but it may be carried by a patient or other user to provide the patient with more mobility. In addition to carrying the control unit 14′, the patient can wear control unit 14′ on a belt, on other articles of clothing, or around his/her neck, for example. In other examples, control unit 14′ may be mounted to a patient's bed to minimize the footprint of system 10 in the area around the patient, or to provide portable muscle stimulation in the event a bed-ridden patient needs to be transported or moved to another location.


Similar to FIG. 1, the system of FIG. 2 may include a controller 16, shown as a handheld controller 16. Handheld controller 16 may include buttons 17, 19 that can be pressed by a patient or other user to control breathing patterns. In one example, pressing one of buttons 17, 19 can initiate a “sigh” breath, which may cause a greater volume of air to enter the patient's lungs than in a previous breath. A sigh breath may result when electrodes 34 of catheter 12 are directed to stimulate one or more of the phrenic nerves 26, 28 at a higher level than a normal breath (i.e., a stimulation train having a longer duration of stimulation or having pulses with a higher amplitude, pulse width, or frequency). Higher amplitude stimulation pulses can recruit additional nerve fibers, which in turn can engage additional muscle fibers to cause stronger and/or deeper muscle contractions. Extended pulse widths or extended durations of the stimulation train can deliver stimulation over longer periods of time to extend the duration of the muscle contractions. In the case of diaphragm muscle stimulation, longer pulse widths have the potential to help expand the lower lung lobes by providing greater or extended negative pressure around the outside of the lungs. Such negative pressure has the potential to help prevent or mitigate a form of low pressure lung injury known as atelectasis. The increased stimulation of the one or more phrenic nerves 26, 28 may result in a more forceful contraction of the diaphragm 30, causing the patient to inhale a greater volume of air, thereby providing a greater amount of oxygen to the patient. Sigh breaths may increase patient comfort.


In other examples, buttons 17, 19 may allow the patient or other user to start and stop stimulation therapy, or to increase or decrease stimulation parameters, including stimulation charge (amplitude×pulse width), frequency of pulses in a stimulation train, or breath rate. LED indicators or a small LCD screen (not shown) on the controller may provide other information to guide or inform the operator regarding the stimulation parameters, the feedback from the system sensors, or the condition of the patient.



FIG. 3 illustrates another example of system 10 in which a control unit 14″ is implanted in the patient, along with catheter 12. System 10 may further include remote controller 16 and a programmer 98 that communicates with control unit 14″ wirelessly. In this embodiment, each of programmer 98, control unit 14″, and remote controller 16 may include a wireless transceiver 92, 94, 96, respectively, so that each of the three components can communicate wirelessly with each other. Control unit 14″ may include all of the electronics, software, and functioning logic necessary to perform the functions described herein. Implanting control unit 14″ as shown in FIG. 3 may allow catheter 12 to function as a permanent breathing pacemaker. Programmer 98 may allow the patient or health professional to modify or otherwise program the nerve stimulation or sensing parameters. Remote controller 16 may be used as described in connection with FIGS. 1 and 2. In other examples, remote controller 16 may be in the form of a smartphone, tablet, watch or other wearable device.


Catheter Features


Referring to FIGS. 1-3, catheter 12 may include a stimulation array comprising a plurality of electrodes 34 or other energy delivery elements. In one example, electrodes 34 may be surface electrodes located on an outer wall of catheter 12. In another example, electrodes 34 may be positioned radially inward relative to the outer wall of catheter 12 (e.g., exposed through openings in the outer wall). In yet another example, the electrodes 34 may include printed electrodes as described in U.S. Pat. No. 9,242,088, which is incorporated by reference herein (see below).


Electrodes 34 may extend partially around the circumference of catheter 12. This “partial” electrode configuration may allow electrodes 34 to target a desired nerve for stimulation, while minimizing application of electrical charge to undesired areas of the patient's anatomy (e.g., other nerves or the heart). As shown in FIG. 1, catheter 12 may include a proximal set 35 of electrodes 34 configured to be positioned proximate to and stimulate left phrenic nerve 26 and a distal set 37 of electrodes 34 configured to be positioned proximate to and stimulate right phrenic nerve 28. As shown in FIG. 5, electrodes 34 may be arranged in rows extending along the length of catheter 12. In one example, proximal set 35 may include two rows, and distal set 37 may include two rows.


Furthermore, the catheters described herein may include any features of the nerve stimulation devices described in the following documents, which are all incorporated by reference herein in their entireties: U.S. Pat. No. 8,571,662 (titled “Transvascular Nerve Stimulation Apparatus and Methods,” issued Oct. 29, 2013); U.S. Pat. No. 9,242,088 (titled “Apparatus and Methods for Assisted Breathing by Transvascular Nerve Stimulation,” issued Jan. 26, 2016); U.S. Pat. No. 9,333,363 (titled “Systems and Related Methods for Optimization of Multi-Electrode Nerve Pacing,” issued May 10, 2016); U.S. application Ser. No. 14/383,285 (titled “Transvascular Nerve Stimulation Apparatus and Methods,” filed Sep. 5, 2014); or U.S. application Ser. No. 14/410,022 (titled “Transvascular Diaphragm Pacing Systems and Methods of Use,” filed Dec. 19, 2014). In addition, the control units described herein can have any of the functionality of the control units described in the above-referenced patent documents (e.g., the control units described herein can implement the methods of nerve stimulation described in the incorporated documents).


During nerve stimulation, one or more electrodes 34 may be selected from the proximal set 35 for stimulation of left phrenic nerve 26, and one or more electrodes 34 may be selected from the distal set 37 for stimulation of right phrenic nerve 28. Catheter 12 may stimulate nerves using monopolar, bipolar, or tripolar electrode combinations, or using any other suitable combination of electrodes 34. In some examples, a second or third stimulation array can be used to stimulate other respiratory muscles. When multiple nerves or muscles are being stimulated, the controller and sensors described herein may be used to coordinate stimulation to achieve the desired muscle activation, breath, or level of respiratory support.


Catheter 12 may further include one or more lumens. Each lumen may extend from a proximal end of catheter 12 to a distal end of catheter 12, or to a location proximate the distal end of catheter 12. The lumens may contain medical devices, such as a guidewire or an optical fiber camera. Furthermore, the one or more lumens may be used for any suitable purpose, such as drawing blood samples or providing a pathway for delivering medications into the patient. In some examples, lumens may contain or be fluidly connected to sensors, such as blood gas sensors or pressure sensors.


In this disclosure, the figures illustrating catheter 12 may each illustrate different features and different combinations of features. However, catheter 12 may include any combination of the features that are described herein. Accordingly, the features of catheter 12 are not limited to the specific combinations shown in the various figures.


Referring to FIG. 2, a hub 36 may be connected to the proximal end of catheter 12. Hub 36 may include a conductive surface and can act as a reference electrode during monopolar stimulation or sensing. In some embodiments, hub 36 may be sutured on a patient's skin. In addition, hub 36 may be used as an ECG electrode.



FIG. 4 illustrates catheter 12 inserted into left jugular vein 32 and superior vena cava 24. As described above, catheter 12 includes a plurality of electrodes 34, with proximal electrodes 34 positioned near left phrenic nerve 26 and distal electrodes 34 positioned near right phrenic nerve 28. Catheter 12 may further include three lumens (not shown) that connect with extension lumens 38, 40, 42 that extend proximally from hub 36. The distal portion of catheter 12 may be configured to assume a helical shape 44 when positioned within the patient. Helical shape 44 may help anchor catheter 12 to the vessel wall to stabilize catheter 12 during nerve stimulation. Furthermore, helical shape 44 may allow electrodes 34 to be positioned at different radial positions within the vessel, which may be useful when selecting electrodes for nerve stimulation. For example, in certain instances it may be desirable to stimulate the nerve with electrodes 34 that are closer to the nerve (e.g., to obtain a stronger diaphragm response), and in other instances it may be desirable to stimulate the nerve with electrodes 34 that are farther away from the nerve (e.g., to obtain a weaker diaphragm response, or prevent stimulation of the vagus nerve).


In one example, helical shape 44 may be obtained by using a stiffening wire inserted into a lumen of catheter 12 via an extension lumen 38, 40, or 42. The stiffening wire may include a shape-memory material (e.g., Nitinol) biased to a helical shape, stainless steel, or any other suitable material. The portion of catheter 12 configured to assume the helical shape 44 may include materials having a lower stiffness than other portions of catheter 12. For example, the materials along helical shape 44 may be thinner or more flexible than the materials along the remaining length of catheter 12. In another example, catheter 12 may include a temperature-activated shape memory material (e.g., Nitinol) along a portion of its length, such that the shape-memory material of catheter 12 may have a substantially straight shape at room temperature and may assume a helical shape when heated within the patient's body.


In some examples, the proximal portion of catheter 12 additionally or alternatively may have a feature, similar to the distal portion of catheter 12, to allow it to assume a helical shape when positioned within left jugular vein 32 (or left subclavian vein 22). Any proximal helical shape may be obtained or result from any of the features described in connection with helical shape 44. If both the proximal and distal portions of catheter 12 assume a helical shape when positioned within the patient, both the proximal and distal electrodes 34 may be fixed relative to the left and right phrenic nerves 26, 28, respectively. To account for body movements when the patient breathes or moves, catheter 12 may further include a helical shape along a central portion of catheter 12. In one example, the diameter of an expanded helical shape in the central portion may be less than the diameter of the vessel wall, so that the central helical shape is not fixed relative to the vessel wall. Accordingly, the central helical portion may allow catheter 12 to freely expand and contract in length within the vessel as body movements cause the distance between the proximal helix and the distal helix (which may be fixed relative to the vessel walls) to vary. The central helical shape may be obtained or result from any of the features described in connection with helical shape 44.


Referring to FIG. 5, each of the extension lumens 38, 40, and 42 may end in a proximal-most port 38a, 40a, and 42a, respectively. Further, the lumens internal to catheter 12 may terminate in one or more distal ports. In one example, internal lumens that communicate with lumens 38, 40, and 42 terminate at a distal port 48, medial port 50, and proximal port 52, respectively. Lumens 38, 40, 42 and their corresponding internal lumens may be used to transport fluid to and from the patient, such as to deliver medications or withdraw blood or other bodily fluids. In other examples, these lumens may be used to hold a guidewire, stiffening wire, optical fiber camera, sensors, or other medical devices. FIG. 5 illustrates an optical fiber camera 46 inserted into lumen 38, extending through a corresponding internal lumen, and exiting from distal port 48.



FIG. 6 illustrates another example of catheter 12. Catheter 12 is similar to the catheter of FIG. 5, except electrodes 34 may be formed by conductive inks (such as silver, gold, graphine, or carbon flakes suspended in polymer or other media) printed on the surface of catheter 12, as described in U.S. Pat. No. 9,242,088, incorporated by reference herein (see above). These conductive inks may be deposited and adhered directly onto catheter 12 and sealed, except for the exposed electrodes 34, with an outer polyurethane or other flexible insulative film. The exposed electrodes 34 may be coated (e.g., with titanium nitride) for purposes such as one or more of: enhancing electrical properties, such as conductivity and surface area; providing corrosion resistance; and reducing the potential for formation of silver oxide, which could be toxic. As can be seen in FIG. 6, the conductive ink trace of distal electrodes may travel proximally along catheter 12 past the more proximal electrodes 34. FIG. 6 further illustrates catheter 12 having an ultrasound transducer 54 at a distal end of catheter 12, which will be described further below.


Detailed System Components



FIG. 7 illustrates a block diagram of the various components of system 10. The electrodes 34a-34j, hub 36, and lumens 38, 40, 42, 58, and 60 may be part of catheter 12 described herein. Catheter 12 may have any number of electrodes and any number of lumens. Five lumens are illustrated in FIG. 7, but in different examples, the catheter may include one, two, three, four, or more than five lumens. In one example, catheter 12 may have three lumens (e.g., extension lumens 38, 40, 42 and corresponding internal lumens), which each may hold one or more of a guidewire or optical fiber camera, or may be used for fluid delivery or blood sample extraction (box 43). In another example, catheter 12 may include four lumens, with one lumen 58 holding or fluidly connected to a pressure sensor 90, one lumen 60 holding or fluidly connected to a blood gas sensor 62, and the other two lumens holding a guidewire or optical fiber camera and/or being used for fluid delivery or blood sample extraction. It should be understood that any lumen of system 10 may contain or be fluidly connected to any of the devices (e.g., sensors, guidewire, optical fiber camera) described herein and/or may be used for any of the functions described herein (e.g., fluid delivery, blood sample extraction).


System 10 may include a controller 64, which may be part of any of the control units described herein. Each of the components of system 10 may be operably coupled to the controller 64, and controller 64 may manage operation of electrodes 34 during nerve stimulation, control the gathering of information by various sensors and electrodes 34, and control fluid delivery or extraction. It should be understood that the various modules described herein may be part of a computing system and are separated in FIG. 7 for explanatory purposes only; it is not necessary for the modules to be physically separate.


Electrodes 34a-34j may be electronically coupled to switching electronics 56, which may be communicably coupled to controller 64. As shown in FIG. 7, a portion of electrodes 34 may be distal electrodes 34a-34d, and a portion of electrodes 34 may be proximal electrodes 34g-34j. Other electrodes 34, such as electrodes 34e and 34f, may be positioned between the proximal and distal electrodes and, depending on the placement of catheter 12, may be used for stimulating either left or right phrenic nerves 26, 28. Hub 36 also may be connected to switching electronics 56 and may be used as an electrode.


Electrodes 34a-34j may be used for both electrically stimulating nerves and for gathering physiological information. When being used for nerve stimulation, a first combination of electrodes (e.g., one, two, three, or more electrodes) may be electrically coupled to a first stimulation module channel 70 for stimulation of a first nerve (e.g., the right phrenic nerve) and a second combination of electrodes (e.g., one, two, three, or more electrodes) may be electrically coupled to a second stimulation module channel 72 for stimulation of a second nerve (e.g., the left phrenic nerve). Electrical signals may be sent from the first and second stimulation module channels 70, 72 to the electrode combinations to cause the electrodes to stimulate the nerves. In other examples, more than two electrode combinations (e.g., 3, 4, or more) may be used to stimulate one or more target nerves, and system 10 may include more than two stimulation module channels.


Electrodes 34a-34f may be further configured to sense physiological information from a patient, such as nerve activity, ECG, or electrical impedance, as will be described further below. When being used for sensing, one or more of electrodes 34a-34f may be electronically coupled to a signal acquisition module 68. Signal acquisition module 68 may receive signals from electrodes 34.


Switching electronics 56 may selectively couple electrodes 34 to first stimulation module channel 70, second stimulation module channel 72, or signal acquisition module 68. For example, if an electrode 34 (e.g., electrode 34a) is being used to acquire a signal, such as an ECG signal, that electrode 34 may be coupled via switching electronics 56 to signal acquisition module 68. Similarly, if a pair of electrodes (e.g., electrodes 34b and 34d) is being used to stimulate right phrenic nerve 28, those electrodes may be coupled via switching electronics 56 to first stimulation module channel 70. Finally, if a pair of electrodes (e.g., electrodes 34g and 34h) is being used to stimulate left phrenic nerve 26, those electrodes may be coupled via switching electronics 56 to second stimulation module channel 72. Switching electronics 56 may change which electrodes 34 are used for stimulation and which are used for sensing at any given time. In one example, any electrode 34 can be used for nerve stimulation and any electrode 34 can be used for sensing functions described herein. In other words, each electrode 34 may be configured to stimulate nerves, and each electrode 34 may be configured to sense physiological information.


Signal acquisition module 68 may further be coupled to one or more sensors configured to gather physiological information from a patient. For example, system 10 may include one or more of blood gas sensor 62 or pressure sensor 90. These sensors may be located in lumens of catheter 12, outside of the patient in fluid communication with a lumen, on an outer surface of catheter 12, or in any other suitable location. In one example, blood gas sensor 62 may be housed in or fluidly connected to lumen 60, while pressure sensor 90 may be housed in or fluidly connected to lumen 58. Blood gas sensor 62 may measure the amount of O2 or CO2 in the patient's blood. Pressure sensor 90 may measure the central venous pressure (CVP) of the patient.


Signal acquisition module 68 may transmit the signals received from one or more of electrodes 34, blood gas sensor 62, and/or pressure sensor 90 to the appropriate processing/filtering module of system 10. For example, signals from pressure sensor 90 may be transmitted to a central venous pressure signal processing/filtering module 84, where the signals are processed and filtered to aid in interpretation of CVP information. Similarly, signals from blood gas sensor 62 may be transmitted to a blood gas signal processing/filtering module 86 for processing and filtering to determine blood gas levels. Signals from electrodes 34, when they are used for sensing, may be sent to nerve signal processing/filtering module 80, ECG signal processing/filtering module 82, or impedance signal processing/filtering module 88, as appropriate. Signals from electrodes 34 or other sensors may be sent to amplification module 78, if necessary, to amplify the signals prior to being sent to the appropriate processing/filtering module.


Controller 64 may further communicate with display 74, which may serve as a user interface and may have a touch screen 18 (see FIG. 1). System 10 may further include software/firmware 76, which may contain the instructions necessary for carrying out the various functions described herein. Finally, system 10 may include data storage 79, for storing information gathered during sensing operations of catheter 12, and/or for storing instructions related to the operation of any of the modules or instructions for carrying out any of the functions described herein. Catheter 12 may contain unique identification features (e.g., RFID), and in the event the system 10 described herein (e.g., having one or more of controllers/programmers 14, 14′, 14″, 98, 64) is used to treat multiple patients concurrently, the catheter identification feature may allow the system 10 to uniquely identify each patient and access that patient's stored patient data.


Catheter Positioning


Catheter 12 may include a variety of positioning features that may help a user to position catheter 12 within a patient. Some positioning features may be visualization aids, such as optical fiber camera 46 shown in FIG. 5 or ultrasound transducer 54 shown in FIG. 6. Other positioning features may be sensors to sense physiological parameters, such as pressure sensor 90. Electrodes 34, which can be used to stimulate a nerve, also may be used as sensors to gather information that can then be used to position catheter 12. For example, electrodes 34 may gather information related to nerve activity (e.g., the left or right phrenic nerve), ECG signals, and/or impedance. Accordingly, a sensing electrode 34 may be considered a positioning feature. Each of the positioning features and how they are used to help position catheter 12 will be described in further detail below.


Catheter 12 may include any combination of positioning features, including one or more visualization aids, sensors (e.g., pressure), or electrodes capable of sensing various types of information. Similarly, the control units described herein, whether on a cart, wearable on a patient, or wireless, may be configured to process information gathered by the various positioning features described herein (e.g., visualization aids, sensors, and electrodes), as well as perform the various computerized functions described herein.


Referring back to FIG. 5, optical fiber camera 46 may be positioned within extension lumen 38 and its corresponding internal lumen within catheter 12, either temporarily or as an integral, permanent component of catheter 12. It should be understood that optical fiber camera 46 could be inserted into any of the extension lumens 38, 40, 42 and internal lumens, and could exit any of the ports 48, 50, 52. Optical fiber camera 46 may be used to aid in positioning of catheter 12 within the patient. For example, images from optical fiber camera 46 may be transmitted in real time to a health professional or other user during a procedure, who may rely on the images to guide catheter 12 through the patient's vessels and/or to adjust the position of the catheter within the vessels.


Referring back to FIG. 6, ultrasound transducer 54 may be used in addition to or instead of optical fiber camera 46 to obtain information useful for positioning catheter 12 within the patient. Ultrasound transducer 54 may be secured temporarily or permanently to the exterior of catheter 12, as shown in FIG. 6, or may be positioned temporarily or permanently within a lumen of catheter 12 (e.g., positioned to extend from the distal end of a lumen of catheter 12). Positioning ultrasound transducer 54 near the distal tip of catheter 12 may allow the user to view the inside of vessels and also ensure that the tip of catheter 12 is not positioned in an undesired location (e.g., in the atrium of the heart). For example, ultrasound transducer 54 may allow visualization of a heart valve, which could indicate that the catheter 12 has entered the atrium and may need to be retracted.


In addition to allowing a user to see the inside of the patient's vessels, the ultrasound images may provide information (e.g., calculated or visual) about the diameter of blood vessels and/or blood flow within the vessels. The user may then use vessel diameter information, blood flow, and real time images of the inside of the patient's vessels to position catheter 12 in a desired position.


CVP measurements from pressure sensor 90 may further aid in positioning catheter 12 within the patient. Normal values may vary between 4-12 cmH2O. The CVP waveform may change based on the location, relative to the patient's heart, of the port (e.g., 46, 48, or 50) in communication with pressure sensor 90. In one example, CVP measurements may decline as the relevant port approaches the patient's heart. A user may read the changing CVP waveforms to help position the catheter 12 in a desired location relative to the patient's heart.


The CVP waveform has several components. The (a) wave corresponds to the right atrial contraction and correlates with the P wave on the ECG. The (c) wave corresponds to the cusp of the tricuspid valve protruding backwards through the atrium, as the right ventricle begins to contract. The (c) wave correlates with the end of the QRS complex on the ECG. The (x) descent corresponds to the movement of the right ventricle, which descends as it contracts. The downward movement decreases the pressure in the right atrium. At this stage, there is also atrial diastolic relaxation, which further decreases the right atrial pressure. The (x) descent happens before the T wave on the ECG. The (v) wave occurs as blood fills the right atrium and hits the tricuspid valve, causing a back-pressure wave. The (v) wave occurs after the T wave of the ECG. The (y) descent is a pressure decrease caused by the tricuspid valve opening in early ventricular diastole and occurs before the P wave of the ECG. The amplitudes of a, c, x, v, y may change depending on the position of the catheter with respect to the heart. The signature change of the CVP waveform can guide in the placement of catheter 12.


In one example, a method for positioning intravascular catheter 12 may include positioning catheter 12 in a first position in a venous system of a patient, wherein catheter 12 includes a plurality of electrodes 34 and at least one lumen extending from a proximal end of catheter 12 to a distal end of catheter 12, and each electrode 34 of the plurality of electrodes 34 is configured to emit electrical signals to stimulate a nerve; measuring a central venous pressure of the patient using a pressure sensor 90 fluidly connected to the at least one lumen; and based on the central venous pressure, adjusting catheter 12 to a second position different from the first position.


Nerve signals acquired by electrodes 34 also may be used to aid in positioning catheter 12 within a patient. The electrical signal from a nerve may be amplified by amplification module 78 and processed by nerve signal processing/filtering module 80. The amplified and filtered signals from one or more electrodes 34 then may be compared to an expected signal from the targeted nerve (e.g., left or right phrenic nerve) to identify electrodes 34 in close proximity to the target nerve and to identify the optimal one or more electrodes for nerve stimulation. For example, electrodes 34 returning a higher strength and/or higher quality signal may be located closer to the target nerve.


More specifically, phrenic nerve activity can be recorded using bipolar or monopolar electrodes. Phrenic nerve discharge can be amplified and filtered (e.g., 100 Hz to 5 kHz), and a moving average can be obtained using a third-order Paynter filter with a 20 or 50 ms time constant. Phrenic nerve discharge also can be filtered at 10 Hz to 5 kHz for analysis of spectral composition. A sampling rate of 1-10 kHz can be used to capture the nerve activity.


The parameters acquired during nerve activity sensing can be used to detect if the signal is from the phrenic nerve or another nerve. Sensed parameters can include a number of physiological parameters, such as amplitude, inspiration duration, and/or breathing rate. For example, if the sensed amplitude shows proximity of the electrodes 34 to the nerve and the nerve is a phrenic nerve, the duration of pulses in a train should match the sensed inspiration duration, and the frequency of the trains should match the sensed breathing rate. Furthermore, the sensed signals from a nerve can be compared to known nerve signatures (e.g., of phrenic nerves) to confirm that the nerve signal is from the desired nerve.


Electrodes 34 (e.g., two or three) may be used to acquire ECG signals, with hub 36 optionally being used as a reference electrode. The ECG signal (e.g., morphology, amplitudes, and spectral content) may vary depending on the location, relative to the patient's heart, of the electrodes being used to measure the signal. Monitoring changes in the ECG signal as catheter 12 is being positioned may aid in identifying desired or undesired placement. For example, it may be undesired for catheter 12 to be placed in the atrium of the patient's heart.


In one example, one of the distal electrodes 34 on catheter 12 may be designated as a probe. Other electrodes along the length of catheter 12, and in some cases in contact with the skin of the patient, may be used to detect an ECG signal, which can optionally be displayed by control unit 14 via screen 18. Catheter 12 may be advanced through superior vena cava 24 towards the heart. As catheter 12 enters a region proximate the right atrium, or enters the right atrium, the P-wave portion of the ECG may become elevated and create an augmented peaked P-wave, indicating that the tip of the catheter 12 lies in or very close to the right atrium. The operator can observe the change in P-wave, or the control unit 14 can utilize an algorithm to detect the change and provide a visual, audible or other signal to the operator. For example, an LED on catheter hub 36, control unit 14, or remote controller 16 can change from green to yellow and then to red as the P-wave changes indicate that the catheter 12 is approaching and then is positioned within the right atrium. The catheter 12 can then be withdrawn slowly until the P-wave starts to diminish. The catheter 12 can then be withdrawn a further 1-2 cm, thereby positioning the catheter tip in the distal portion of superior vena cava 24.


In this example, the positive deflection in the P-wave occurs when current flows to the probing electrode, and a negative deflection when it flows away. The P-wave depolarizes down the right atrium from the SA node, away from an electrode 34 in superior vena cava 24, and is therefore negative. The amplitude of the P-wave is related to the inverse square rule, whereby the amplitude is inversely proportional to the square of the distance from the current source. Thus, the P-wave increases greatly in negative amplitude as catheter 12 approaches the atrium. When the tip enters the atrium, it is just beyond the SA node, and the first portion of the P-wave depolarizes towards it. This results in a brief, small positive deflection followed instantly by a deep negative deflection.


Alternatively, a distal combination of electrodes 34 (e.g., a distal pair) and a proximal combinations of electrodes 34 (e.g., a proximal pair) can be used to obtain, respectively, a distal and proximal ECG signal having a P-wave. The P-waves can be compared using standard signal processing techniques and a delta value can be determined as the catheter 12 is advanced through the vessel (e.g. superior vena cava 24) towards the heart. As catheter 12 is advanced in close proximity to or into the atrium, the delta value will change significantly, exceeding a predetermined value. The system 10 can provide an indicator to the operator, as described previously, and catheter 12 can be withdrawn 1 to 2 cm. This method can also utilize one or more reference electrodes 34 located along the length of the catheter or positioned externally on the patient's body.


Electrodes 34 also may be used to measure impedance, which can provide information relevant to positioning catheter 12. Impedance may be measured between any two electrodes 34 of catheter 12. In one example, however, impedance may be measured between: a) either a proximal-most electrode 34 or hub 36, and b) a distal-most electrode.


The impedance presented to injected current may be dependent on the conductivity of the fluid, or adjacent tissue, in the local area between a pair of sensing electrodes 34. The conductivity further may depend on the cross-sectional area of the blood vessel at the site of the sending electrodes 34. The impedance of an electrode 34 may vary depending on the medium in which it is resting. For example, an electrode 34 placed in a relatively large body of conductive fluid may have a lower impedance than one resting against a vessel wall. The impedance of an electrode 34 can therefore be used to determine whether it is adjacent to a vessel wall or resting in a larger body of conductive fluid.


In one example, when catheter 12 is inserted into a patient, electrodes 34 that are on a proximal portion of catheter 12 may have a higher impedance than other electrodes 34, because the proximal portion of catheter 12 may be positioned in tissue (e.g., fatty) near an insertion site, rather than resting in the fluid of a blood vessel. Electrodes 34 farther down the shaft of catheter 12, towards a central portion of catheter 12, might have progressively lower impedances as the diameter of the vessel increases (e.g., as the vessel approaches superior vena cava 24). Electrodes 34 on the portion of catheter 12 that is floating in fluid in superior vena cava 24 might have a low impedance. Electrodes 34 on the distal portion of catheter 12, at or near the tip of catheter 12, might be in direct contact with the vessel wall and therefore may have a higher impedance. A graph of the impedances of all of the electrodes 34 in this example may have a U-shaped curvature, as impedances may be higher at each end of catheter 12 and lower towards the central portion of catheter 12. The change in impedance of an electrode 34 as it progresses through the patient's vessels can provide information about the location of that electrode 34. In addition, the differences in impedances of electrodes 34 along the length of catheter 12 may provide information about the placement of catheter 12.


In one example, catheter 12 may be placed in a vessel that varies in diameter, with distal electrodes 34 resting in a desired vessel (e.g., in superior vena cava 24). The impedances of different, more proximal electrodes would be expected to vary depending on their position in the venous system. In one example, catheter 12, when placed in a desired position, would be expected to include: 1) electrodes 34 whose impedances are reduced as the electrodes 34 approach the wall of a vessel (e.g., superior vena cava 24); and 2) electrodes 34 having impedance profiles with a desired shape. In one example, measured impedances may be compared to impedance thresholds or profiles stored in data storage 79, to determine if one or more electrodes 34 are properly placed.


In another example, the impedances of distal electrodes can be compared to the impedances of proximal electrodes as the catheter 12 is advanced through superior vena cava 24 towards the atrium. As the distal electrodes enter the atrium, the difference between the distal and proximal impedance measurements may exceed a predetermined threshold allowing the system 10 to provide an indication to the operator. Catheter 12 can then be withdrawn (or advanced depending on the application) to the desired location. Signal filtering, processing, and analytical techniques known in the art can be used to assess the impedance measurements in real time.


A catheter 12 that is under-inserted may have few or no electrodes 34 resting in the desired vessel (e.g., superior vena cava 24), which would result in electrode impedance profiles having different shapes than the desired shape. In addition, a catheter 12 that is over-inserted may have one or more electrodes 34 that are close to, or in contact with, the atrium, which may also result in impedance profiles having different shapes than the desired shape. In one example, the impedance of one or more electrodes 34 is monitored as catheter 12 is inserted into the patient and electrodes 34 move through the patient's venous system. Changes in the impedance profiles can be displayed to the health professional performing the insertion, and the impedance profiles can be used to confirm proper placement of catheter 12.


In one example, a method for positioning intravascular catheter 12 may include positioning catheter 12 in a first position in a venous system of a patient, wherein catheter 12 includes a plurality of electrodes 34, and each electrode 34 of the plurality of electrodes 34 is configured to emit electrical signals to stimulate a phrenic nerve; measuring an impedance between a first electrode 34 of the plurality of electrodes 34 and a second electrode; and based on the measured impedance, adjusting catheter 12 to a second position different from the first position.


In other examples, catheter 12 may include a strain gauge and/or an accelerometer (not shown). Either the strain gauge or the accelerometer may be placed at or near the distal end of catheter 12, in one of the lumens. The strain gauge could detect flex in a distal portion of catheter 12, and the accelerometer could detect movement/acceleration of the distal portion of catheter 12. Information from the strain gauge and/or accelerometer could be used to determine whether the distal end of catheter 12 is in the atrium (e.g., heartbeats may cause movement of the distal end of catheter 12). The strain gauge or the accelerometer could be an integral, permanent part of catheter 12 or could be positioned in a lumen of catheter 12 temporarily during positioning of catheter 12.


Electrode Selection and Determining Stimulation Parameters


Nerve signals acquired by sensing electrodes 34 may be used to select electrodes 34 for nerve stimulation. Electrodes 34 that are closer to a target nerve may sense nerve activity having a higher amplitude, while electrodes 34 that are farther from a target nerve may sense nerve activity having a lower amplitude. If a greater diaphragm response is desired, electrodes 34 that are closer to the nerve, as determined based on received nerve activity signals, may be selected for nerve stimulation. In other cases, if less diaphragm response is desired, electrodes 34 that are farther from the nerve, as determined based on received nerve activity signals, may be selected for nerve stimulation.


Typical nerve signals for, e.g., phrenic nerves, follow a pattern that has distinct characteristics (e.g., spectral characteristics and modulation over time). To select electrodes 34 for nerve stimulation, the sensed nerve signals from different electrodes 34 can be analyzed for their spectral and temporal characteristics. Of electrodes 34 having sensed signal patterns matching typical phrenic nerve activity, the optimal electrodes 34 can be selected based on the amplitude of the signal and how strongly the signal correlates to the typical pattern. In one example, a fast Fourier transform can be used to provide a correlation factor to a reference signal in near real-time. In another example, the sensed signals can be frequency filtered in the frequency range of interest, based on the typical characteristics of the phrenic nerve signal, and then analyzed over time to observe periods or bursts of activity in the frequency range of interest.


In one example, a method for selecting one or more electrodes for nerve stimulation may include inserting intravascular catheter 12 into: a) at least one of left subclavian vein 22 or left jugular vein 32, and b) superior vena cava 24, wherein catheter 12 includes a plurality of electrodes 34, and each electrode 34 of the plurality of electrodes 34 is configured to emit electrical signals to stimulate a nerve; using one or more electrodes 34 of the plurality of electrodes 34 to acquire an electrical signal emitted from the nerve; based on the acquired electrical signal, selecting an electrode 34 or an electrode combination for a nerve stimulation; and using the selected electrode 34 or electrode combination, stimulating the nerve.


The processed nerve activity waveforms additionally may be used to determine parameters for nerve stimulation. The processed waveforms may provide information regarding intrinsic breath rate (e.g., if the patient is attempting to breathe on his/her own) and nerve signal amplitude. The stimulation parameters may be adjusted based on the breath rate of previous stimulated breaths (e.g., to increase or decrease the breath rate, as sensed by the sensing electrodes) and nerve activity resulting from stimulation during previous breaths (e.g., to increase or decrease the strength of stimulation). Various parameters that may be adjusted include stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate). Accordingly, sensed nerve activity signals may be used to determine and adjust the nerve stimulation parameters in a closed-loop system.


Impedance information may be used to determine a breath rate of the patient in order to adjust nerve stimulation parameters (e.g., stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate)). Electrical impedance of lung tissue changes as a function of air content. Accordingly, the electrical impedance of the thorax changes during inhalation and exhalation. The thorax presents an electrical impedance that includes two components: a relatively constant value and a varying value. Changes in impedance may result from the following two effects during inspiration: 1) there is an increase in the gas volume of the chest in relation to the fluid volume, which may cause conductivity to decrease, and 2) the length of the conductance path (e.g., between two electrodes) increases when the lungs expand. These effects may cause impedance to increase during inspiration. There is an approximately linear correlation between the impedance changes and the volume of respirated air. The varying component of impedance (i.e., respirative impedance) generates a varying voltage component when current is injected (e.g., by electrodes 34). This varying voltage component can then be used to determine the person's breathing rate.


Information from blood gas sensor 62 may be used by a health professional, or by controller 64, to adjust stimulation parameters. For example, if blood O2 levels are low (or blood CO2 levels are high) controller 64 may send a signal to electrodes 34 to emit stimulation signals having a higher charge (amplitude×pulse width) or frequency, and may stimulate a sigh breath. Conversely, if blood O2 levels are high (or blood CO2 levels are low), controller 64 may cause electrodes 34 to emit stimulation signals having a lower charge or frequency. Based on information from blood gas sensor 62, the following parameters can be adjusted: stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate).


For any of the parameter adjustments described herein, increasing stimulation pulse amplitude, width and/or frequency may increase lung volume during a stimulated breath. Increasing stimulation duration may increase lung volume and/or increase the amount of time air remains in the lungs during a stimulated breath, allowing for an extended gas exchange period. Increasing the stimulated breath rate may allow for additional gas exchange periods over a given period of time, which may increase the amount and/or speed of gas exchange.


The system 10 and catheter 12 described herein may include any combination of sensing features. For example, catheter 12 may be configured to sense ECG, impedance, nerve activity, blood gas levels, and CVP, and the system 10 may be configured to position catheter 12, select electrodes 34 for stimulation, and select stimulation parameters based on one or more types of information received by sensors or electrodes 34.


Accordingly, the various visualization and sensing functions of system 10 may assist a user in one or more of positioning a transvascular catheter, selecting optimal electrodes for nerve stimulation, or selecting or adjusting parameters for nerve stimulation.


While principles of the present disclosure are described herein with reference to illustrative embodiments for particular applications, it should be understood that the disclosure is not limited thereto. Those having ordinary skill in the art and access to the teachings provided herein will recognize additional modifications, applications, embodiments, and substitution of equivalents all fall within the scope of the embodiments described herein. Accordingly, the invention is not to be considered as limited by the foregoing description.

Claims
  • 1. A method, comprising: inserting a catheter into a first blood vessel and a superior vena cava, wherein the catheter includes a plurality of electrodes;using one or more electrodes of the plurality of electrodes to acquire one or more electrical signals emitted from a nerve;based on the one or more electrical signals, positioning the catheter relative to the nerve and selecting at least one electrode to stimulate the nerve; andstimulating the nerve to cause a contraction of a respiratory muscle.
  • 2. The method of claim 1, further comprising determining whether the one or more electrical signals are from a phrenic nerve.
  • 3. The method of claim 1, further comprising comparing the one or more electrical signals to an expected signal from the nerve.
  • 4. The method of claim 1, wherein the at least one electrode selected for nerve stimulation is positioned closer to the nerve than other electrodes of the plurality of electrodes.
  • 5. The method of claim 1, wherein the at least one electrode selected for nerve stimulation senses nerve activity having a higher amplitude than other electrodes of the plurality of electrodes.
  • 6. The method of claim 1, wherein the first vessel is at least one of: a left subclavian, axillary, cephalic, cardiophrenic, brachial, radial, or left jugular vein.
  • 7. The method of claim 1, wherein the nerve is at least one of a left phrenic nerve or a right phrenic nerve.
  • 8. The method of claim 1, wherein each electrode of the plurality of electrodes is configured to both acquire and emit electrical signals.
  • 9. A method, comprising: inserting a catheter into a first blood vessel and a superior vena cava, wherein the catheter includes a plurality of electrodes, and the plurality of electrodes include proximal electrodes positioned in the first vessel proximate a first nerve and distal electrodes positioned in the superior vena cava proximate a second nerve;using one or more electrodes of the proximal electrodes to acquire a first electrical signal emitted from the first nerve;based on the first electrical signal, selecting at least one electrode of the proximal electrodes to stimulate the first nerve;using one or more electrodes of the distal electrodes to acquire a second electrical signal emitted from the second nerve;based on the second electrical signal, selecting at least one electrode of the distal electrodes to stimulate the second nerve;based on at least one of the first or second electrical signals, positioning the catheter relative to the first or second nerve; andstimulating at least one of the first or second nerves to cause a contraction of a respiratory muscle.
  • 10. The method of claim 9, wherein the first nerve is a left phrenic nerve, and the second nerve is a right phrenic nerve.
  • 11. The method of claim 9, further comprising determining inspiration duration or breathing rate from at least one of the first or second electrical signals.
  • 12. The method of claim 9, wherein the at least one electrode of the proximal electrodes selected to stimulate the first nerve is closer to the first nerve than other electrodes of the proximal electrodes, and the at least one electrode of the distal electrodes selected to stimulate the second nerve is closer to the second nerve than other electrodes of the distal electrodes.
  • 13. The method of claim 9, further comprising determining a correlation factor between the first electrical signal and a reference signal.
  • 14. The method of claim 9, further comprising applying a frequency filter in a desired range to the first electrical signal and analyzing changes in the desired range over time.
  • 15. The method of claim 9, further comprising determining a breath rate from at least one of the first or second electrical signals and adjusting a stimulation parameter based on the breath rate.
  • 16. The method of claim 9, further comprising, after stimulating at least one of the first or second nerves to cause a contraction of the respiratory muscle: using one or more electrodes of the plurality of electrodes to acquire a third electrical signal emitted from the stimulated first or second nerve, andadjusting a stimulation parameter based on the third electrical signal.
  • 17. A method, comprising: inserting a catheter into: a) at least one of a left subclavian vein or left jugular vein, and b) a superior vena cava, wherein the catheter includes a plurality of electrodes, and the plurality of electrodes include proximal electrodes positioned proximate a left phrenic nerve and distal electrodes positioned proximate a right phrenic nerve;using one or more electrodes of the proximal electrodes to acquire a first electrical signal emitted from the left phrenic nerve;based on the first electrical signal, selecting at least one electrode of the proximal electrodes to stimulate the left phrenic nerve;using one or more electrodes of the distal electrodes to acquire a second electrical signal emitted from the right phrenic nerve;based on the second electrical signal, selecting at least one electrode of the distal electrodes to stimulate the right phrenic nerve;based on at least one of the first or second electrical signals, positioning the catheter relative to the left or right phrenic nerve; andstimulating at least one of the left or right phrenic nerves to cause a contraction of a diaphragm.
  • 18. The method of claim 17, wherein each electrode of the plurality of electrodes is configured to both acquire and emit electrical signals.
  • 19. The method of claim 17, further comprising adjusting a stimulation parameter based on at least one of the first or second electrical signals.
  • 20. The method of claim 17, further comprising using one or more electrodes of the plurality of electrodes to sense at least one of an impedance or an ECG signal.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. application Ser. No. 15/666,989, filed Aug. 2, 2017, which is hereby incorporated by reference.

US Referenced Citations (454)
Number Name Date Kind
1693734 Waggoner Dec 1928 A
2532788 Sarnoff Dec 1950 A
2664880 Wales, Jr. Jan 1954 A
3348548 Chardack Oct 1967 A
3470876 Barchilon Oct 1969 A
3769984 Muench Nov 1973 A
3804098 Friedman Apr 1974 A
3817241 Grausz Jun 1974 A
3835864 Rasor et al. Sep 1974 A
3847157 Caillouette et al. Nov 1974 A
3851641 Toole et al. Dec 1974 A
3896373 Zelby Jul 1975 A
3938502 Bom Feb 1976 A
4054881 Raab Oct 1977 A
4072146 Howes Feb 1978 A
4114601 Abels Sep 1978 A
4173228 Van Steenwyk et al. Nov 1979 A
4249539 Vilkomerson et al. Feb 1981 A
4317078 Weed et al. Feb 1982 A
4380237 Newbower Apr 1983 A
4407294 Vilkomerson Oct 1983 A
4416289 Bresler Nov 1983 A
4431005 McCormick Feb 1984 A
4431006 Trimmer et al. Feb 1984 A
4445501 Bresler May 1984 A
4586923 Gould et al. May 1986 A
4587975 Salo et al. May 1986 A
4643201 Stokes Feb 1987 A
4674518 Salo Jun 1987 A
4681117 Brodman et al. Jul 1987 A
4697595 Breyer et al. Oct 1987 A
4706681 Breyer et al. Nov 1987 A
4771788 Millar Sep 1988 A
4819662 Heil, Jr. et al. Apr 1989 A
4827935 Geddes et al. May 1989 A
4830008 Meer May 1989 A
4840182 Carlson Jun 1989 A
4852580 Wood Aug 1989 A
4860769 Fogarty et al. Aug 1989 A
4905698 Strohl, Jr. et al. Mar 1990 A
4911174 Pederson et al. Mar 1990 A
4934049 Kiekhafer et al. Jun 1990 A
4944088 Doan et al. Jul 1990 A
4951682 Petre Aug 1990 A
4957110 Vogel et al. Sep 1990 A
4989617 Memberg et al. Feb 1991 A
5005587 Scott Apr 1991 A
5042143 Holleman et al. Aug 1991 A
5056519 Vince Oct 1991 A
5115818 Holleman et al. May 1992 A
5146918 Kallok et al. Sep 1992 A
5170802 Mehra Dec 1992 A
5184621 Vogel et al. Feb 1993 A
5224491 Mehra Jul 1993 A
5243995 Maier Sep 1993 A
5267569 Lienhard Dec 1993 A
5314463 Camps et al. May 1994 A
5316009 Yamada May 1994 A
5330522 Kreyenhagen Jul 1994 A
5345936 Pomeranz et al. Sep 1994 A
5383923 Webster, Jr. Jan 1995 A
5411025 Webster, Jr. May 1995 A
5417208 Winkler May 1995 A
5451206 Young Sep 1995 A
5456254 Pietroski et al. Oct 1995 A
5465717 Imran et al. Nov 1995 A
5476498 Ayers Dec 1995 A
5486159 Mahurkar Jan 1996 A
5507725 Savage et al. Apr 1996 A
5524632 Stein et al. Jun 1996 A
5527358 Mehmanesh et al. Jun 1996 A
5531686 Lundquist et al. Jul 1996 A
5555618 Winkler Sep 1996 A
5567724 Kelleher et al. Oct 1996 A
5584873 Shoberg et al. Dec 1996 A
5604231 Smith et al. Feb 1997 A
5665103 Lafontaine et al. Sep 1997 A
5678535 Dimarco Oct 1997 A
5683370 Luther et al. Nov 1997 A
5709853 Iino et al. Jan 1998 A
5716392 Bourgeois et al. Feb 1998 A
5733255 Dinh et al. Mar 1998 A
5755765 Hyde et al. May 1998 A
5776111 Tesio Jul 1998 A
5779732 Amundson Jul 1998 A
5782828 Chen et al. Jul 1998 A
5785706 Bednarek Jul 1998 A
5788681 Weaver et al. Aug 1998 A
5813399 Isaza et al. Sep 1998 A
5814086 Hirschberg et al. Sep 1998 A
RE35924 Winkler Oct 1998 E
5824027 Hoffer Oct 1998 A
5827192 Gopakumaran et al. Oct 1998 A
5944022 Nardella et al. Aug 1999 A
5954761 Machek et al. Sep 1999 A
5967978 Littmann et al. Oct 1999 A
5971933 Gopakumaran et al. Oct 1999 A
5983126 Wittkampf Nov 1999 A
6006134 Hill et al. Dec 1999 A
6096728 Collins et al. Aug 2000 A
6120476 Fling et al. Sep 2000 A
6123699 Webster, Jr. Sep 2000 A
6126649 Vantassel et al. Oct 2000 A
6136021 Tockman et al. Oct 2000 A
6157862 Brownlee et al. Dec 2000 A
6161029 Spreigl et al. Dec 2000 A
6166048 Bencherif Dec 2000 A
6171277 Ponzi Jan 2001 B1
6183463 Webster, Jr. Feb 2001 B1
6198974 Webster, Jr. Mar 2001 B1
6201994 Warman et al. Mar 2001 B1
6212435 Lattner et al. Apr 2001 B1
6216045 Black et al. Apr 2001 B1
6240320 Spehr et al. May 2001 B1
6251126 Ottenhoff et al. Jun 2001 B1
6269269 Ottenhoff et al. Jul 2001 B1
6292695 Webster, Jr. et al. Sep 2001 B1
6295475 Morgan Sep 2001 B1
6360740 Ward et al. Mar 2002 B1
6397108 Camps et al. May 2002 B1
6415183 Scheiner et al. Jul 2002 B1
6415187 Kuzma et al. Jul 2002 B1
6438427 Rexhausen et al. Aug 2002 B1
6445953 Bulkes et al. Sep 2002 B1
6449507 Hill et al. Sep 2002 B1
6463327 Lurie et al. Oct 2002 B1
6508802 Rosengart et al. Jan 2003 B1
6526321 Spehr Feb 2003 B1
6569114 Ponzi et al. May 2003 B2
6584362 Scheiner et al. Jun 2003 B1
6585718 Hayzelden et al. Jul 2003 B2
6602242 Fung et al. Aug 2003 B1
6610713 Tracey Aug 2003 B2
6630611 Malowaniec Oct 2003 B1
6651652 Waard Nov 2003 B1
6682526 Parker et al. Jan 2004 B1
6702780 Gilboa et al. Mar 2004 B1
6718208 Hill et al. Apr 2004 B2
6778854 Puskas Aug 2004 B2
6844713 Steber et al. Jan 2005 B2
6881211 Schweikert et al. Apr 2005 B2
6885888 Rezai Apr 2005 B2
6907285 Denker et al. Jun 2005 B2
6934583 Weinberg et al. Aug 2005 B2
6981314 Black et al. Jan 2006 B2
6999820 Jordan Feb 2006 B2
7018374 Schon et al. Mar 2006 B2
7047627 Black et al. May 2006 B2
7071194 Teng Jul 2006 B2
7072720 Puskas Jul 2006 B2
7077823 McDaniel Jul 2006 B2
7082331 Park et al. Jul 2006 B1
7130700 Gardeski et al. Oct 2006 B2
7142903 Rodriguez et al. Nov 2006 B2
7149585 Wessman et al. Dec 2006 B2
7155278 King et al. Dec 2006 B2
7168429 Matthews et al. Jan 2007 B2
7184829 Hill et al. Feb 2007 B2
7206636 Turcott Apr 2007 B1
7225016 Koh May 2007 B1
7225019 Jahns et al. May 2007 B2
7229429 Martin et al. Jun 2007 B2
7231260 Wallace et al. Jun 2007 B2
7235070 Vanney Jun 2007 B2
7269459 Koh Sep 2007 B1
7277757 Casavant et al. Oct 2007 B2
7283875 Larsson et al. Oct 2007 B2
7340302 Falkenberg et al. Mar 2008 B1
7363085 Benser et al. Apr 2008 B1
7363086 Koh et al. Apr 2008 B1
7416552 Paul et al. Aug 2008 B2
7421296 Benser et al. Sep 2008 B1
7454244 Kassab et al. Nov 2008 B2
7519426 Koh et al. Apr 2009 B1
7553305 Honebrink et al. Jun 2009 B2
7555349 Wessman et al. Jun 2009 B2
7569029 Clark et al. Aug 2009 B2
7591265 Lee et al. Sep 2009 B2
7593760 Rodriguez et al. Sep 2009 B2
7613524 Jordan Nov 2009 B2
7636600 Koh Dec 2009 B1
7670284 Padget et al. Mar 2010 B2
7672728 Libbus et al. Mar 2010 B2
7672729 Koh et al. Mar 2010 B2
7676275 Farazi et al. Mar 2010 B1
7771388 Olsen et al. Aug 2010 B2
7783362 Whitehurst et al. Aug 2010 B2
7794407 Rothenberg et al. Sep 2010 B2
7797050 Libbus et al. Sep 2010 B2
7813805 Farazi Oct 2010 B1
7819883 Westlund et al. Oct 2010 B2
7840270 Ignagni et al. Nov 2010 B2
7853302 Rodriguez Dec 2010 B2
7869865 Govari et al. Jan 2011 B2
7891085 Kuzma et al. Feb 2011 B1
7925352 Stack et al. Apr 2011 B2
7949409 Bly et al. May 2011 B2
7962215 Ignagni et al. Jun 2011 B2
7970475 Tehrani et al. Jun 2011 B2
7972323 Bencini et al. Jul 2011 B1
7974693 David et al. Jul 2011 B2
7979128 Tehrani et al. Jul 2011 B2
8000765 Rodriguez et al. Aug 2011 B2
8021327 Selkee Sep 2011 B2
8036750 Caparso et al. Oct 2011 B2
8052607 Byrd Nov 2011 B2
8104470 Lee et al. Jan 2012 B2
8116872 Tehrani et al. Feb 2012 B2
8121692 Haefner et al. Feb 2012 B2
8135471 Zhang et al. Mar 2012 B2
8140164 Tehrani et al. Mar 2012 B2
8160701 Zhao et al. Apr 2012 B2
8160711 Tehrani et al. Apr 2012 B2
8195297 Penner Jun 2012 B2
8200336 Tehrani et al. Jun 2012 B2
8206343 Racz Jun 2012 B2
8233987 Gelfand et al. Jul 2012 B2
8233993 Jordan Jul 2012 B2
8239037 Glenn et al. Aug 2012 B2
8244358 Tehrani et al. Aug 2012 B2
8244359 Gelfand et al. Aug 2012 B2
8244378 Bly et al. Aug 2012 B2
8255056 Tehrani Aug 2012 B2
8256419 Sinderby et al. Sep 2012 B2
8265759 Tehrani et al. Sep 2012 B2
8275440 Rodriguez et al. Sep 2012 B2
8280513 Tehrani et al. Oct 2012 B2
8335567 Tehrani et al. Dec 2012 B2
8348941 Tehrani Jan 2013 B2
8369954 Stack et al. Feb 2013 B2
8388541 Messerly et al. Mar 2013 B2
8388546 Rothenberg Mar 2013 B2
8391956 Zellers et al. Mar 2013 B2
8401640 Zhao et al. Mar 2013 B2
8401651 Caparso et al. Mar 2013 B2
8406885 Ignagni et al. Mar 2013 B2
8412331 Tehrani et al. Apr 2013 B2
8412350 Bly Apr 2013 B2
8428711 Lin et al. Apr 2013 B2
8428726 Ignagni et al. Apr 2013 B2
8433412 Westlund et al. Apr 2013 B1
8467876 Tehrani Jun 2013 B2
8473068 Farazi Jun 2013 B2
8478412 Ignagni et al. Jul 2013 B2
8478413 Karamanoglu et al. Jul 2013 B2
8478426 Barker Jul 2013 B2
8483834 Lee et al. Jul 2013 B2
8504158 Karamanoglu et al. Aug 2013 B2
8504161 Kornet et al. Aug 2013 B1
8509901 Tehrani Aug 2013 B2
8509902 Cho et al. Aug 2013 B2
8509919 Yoo et al. Aug 2013 B2
8512256 Rothenberg Aug 2013 B2
8522779 Lee et al. Sep 2013 B2
8527036 Jalde et al. Sep 2013 B2
8560072 Caparso et al. Oct 2013 B2
8571662 Hoffer Oct 2013 B2
8617228 Wittenberger et al. Dec 2013 B2
8620412 Griffiths et al. Dec 2013 B2
8620450 Tockman et al. Dec 2013 B2
8626292 McCabe et al. Jan 2014 B2
8630707 Zhao et al. Jan 2014 B2
8676323 Ignagni et al. Mar 2014 B2
8696656 Abboud et al. Apr 2014 B2
8706223 Zhou et al. Apr 2014 B2
8706235 Karamanoglu Apr 2014 B2
8706236 Ignagni et al. Apr 2014 B2
8718763 Zhou et al. May 2014 B2
8725259 Kornet et al. May 2014 B2
8755889 Scheiner Jun 2014 B2
8774907 Rothenberg Jul 2014 B2
8781578 McCabe et al. Jul 2014 B2
8781582 Ziegler et al. Jul 2014 B2
8781583 Cornelussen et al. Jul 2014 B2
8801693 He et al. Aug 2014 B2
8838245 Lin et al. Sep 2014 B2
8858455 Rothenberg Oct 2014 B2
8897879 Karamanoglu et al. Nov 2014 B2
8903509 Tockman et al. Dec 2014 B2
8909341 Gelfand et al. Dec 2014 B2
8914113 Zhang et al. Dec 2014 B2
8918169 Kassab et al. Dec 2014 B2
8942824 Yoo et al. Jan 2015 B2
9042981 Yoo et al. May 2015 B2
9125578 Grunwald Sep 2015 B2
9242088 Thakkar et al. Jan 2016 B2
9333363 Hoffer et al. May 2016 B2
9345422 Rothenberg May 2016 B2
9415188 He et al. Aug 2016 B2
9532724 Grunwald Jan 2017 B2
9615759 Hurezan Apr 2017 B2
20010052345 Niazi Dec 2001 A1
20020026228 Schauerte Feb 2002 A1
20020065544 Smits et al. May 2002 A1
20020087156 Maguire et al. Jul 2002 A1
20020128546 Silver Sep 2002 A1
20020188325 Hill et al. Dec 2002 A1
20030078623 Weinberg et al. Apr 2003 A1
20030195571 Burnes et al. Oct 2003 A1
20040003813 Banner et al. Jan 2004 A1
20040010303 Bolea et al. Jan 2004 A1
20040044377 Larsson et al. Mar 2004 A1
20040064069 Reynolds et al. Apr 2004 A1
20040077936 Larsson et al. Apr 2004 A1
20040088015 Casavant et al. May 2004 A1
20040111139 McCreery Jun 2004 A1
20040186543 King et al. Sep 2004 A1
20040210261 King et al. Oct 2004 A1
20050004565 Vanney Jan 2005 A1
20050013879 Lin et al. Jan 2005 A1
20050021102 Ignagni et al. Jan 2005 A1
20050033137 Oral et al. Feb 2005 A1
20050043765 Williams et al. Feb 2005 A1
20050070981 Verma Mar 2005 A1
20050075578 Gharib et al. Apr 2005 A1
20050085865 Tehrani Apr 2005 A1
20050085866 Tehrani Apr 2005 A1
20050085867 Tehrani et al. Apr 2005 A1
20050085868 Tehrani et al. Apr 2005 A1
20050085869 Tehrani et al. Apr 2005 A1
20050096710 Kieval May 2005 A1
20050109340 Tehrani May 2005 A1
20050113710 Stahmann et al. May 2005 A1
20050115561 Stahmann et al. Jun 2005 A1
20050131485 Knudson et al. Jun 2005 A1
20050138791 Black et al. Jun 2005 A1
20050138792 Black et al. Jun 2005 A1
20050143787 Boveja et al. Jun 2005 A1
20050165457 Benser et al. Jul 2005 A1
20050182454 Gharib et al. Aug 2005 A1
20050187584 Denker et al. Aug 2005 A1
20050192655 Black et al. Sep 2005 A1
20050251238 Wallace et al. Nov 2005 A1
20050251239 Wallace et al. Nov 2005 A1
20050288730 Deem et al. Dec 2005 A1
20060030894 Tehrani Feb 2006 A1
20060035849 Spiegelman Feb 2006 A1
20060058852 Koh et al. Mar 2006 A1
20060074449 Denker et al. Apr 2006 A1
20060122661 Mandell Jun 2006 A1
20060122662 Tehrani et al. Jun 2006 A1
20060130833 Younes Jun 2006 A1
20060142815 Tehrani et al. Jun 2006 A1
20060149334 Tehrani et al. Jul 2006 A1
20060155222 Sherman et al. Jul 2006 A1
20060167523 Tehrani et al. Jul 2006 A1
20060188325 Dolan Aug 2006 A1
20060195159 Bradley et al. Aug 2006 A1
20060217791 Spinka et al. Sep 2006 A1
20060224209 Meyer Oct 2006 A1
20060229677 Moffitt et al. Oct 2006 A1
20060247729 Tehrani et al. Nov 2006 A1
20060253161 Libbus et al. Nov 2006 A1
20060253182 King Nov 2006 A1
20060258667 Teng Nov 2006 A1
20060259107 Caparso et al. Nov 2006 A1
20060282131 Caparso et al. Dec 2006 A1
20060287679 Stone Dec 2006 A1
20070005053 Dando Jan 2007 A1
20070021795 Tehrani Jan 2007 A1
20070027448 Paul et al. Feb 2007 A1
20070087314 Gomo Apr 2007 A1
20070093875 Chavan et al. Apr 2007 A1
20070106357 Denker et al. May 2007 A1
20070112403 Moffitt et al. May 2007 A1
20070118183 Gelfand et al. May 2007 A1
20070150006 Libbus et al. Jun 2007 A1
20070168007 Kuzma et al. Jul 2007 A1
20070173900 Siegel et al. Jul 2007 A1
20070191908 Jacob et al. Aug 2007 A1
20070196780 Ware et al. Aug 2007 A1
20070203549 Demarais et al. Aug 2007 A1
20070208388 Jahns et al. Sep 2007 A1
20070221224 Pittman et al. Sep 2007 A1
20070240718 Daly Oct 2007 A1
20070250056 Vanney Oct 2007 A1
20070250162 Royalty Oct 2007 A1
20070255379 Williams et al. Nov 2007 A1
20070265611 Ignagni et al. Nov 2007 A1
20070288076 Bulkes et al. Dec 2007 A1
20080065002 Lobl et al. Mar 2008 A1
20080125828 Ignagni et al. May 2008 A1
20080161878 Tehrani et al. Jul 2008 A1
20080167695 Tehrani et al. Jul 2008 A1
20080177347 Tehrani et al. Jul 2008 A1
20080183186 Bly et al. Jul 2008 A1
20080183187 Bly Jul 2008 A1
20080183239 Tehrani et al. Jul 2008 A1
20080183240 Tehrani et al. Jul 2008 A1
20080183253 Bly Jul 2008 A1
20080183254 Bly et al. Jul 2008 A1
20080183255 Bly et al. Jul 2008 A1
20080183259 Bly et al. Jul 2008 A1
20080183264 Bly et al. Jul 2008 A1
20080183265 Bly et al. Jul 2008 A1
20080188903 Tehrani et al. Aug 2008 A1
20080215106 Lee et al. Sep 2008 A1
20080288010 Tehrani et al. Nov 2008 A1
20080288015 Tehrani et al. Nov 2008 A1
20080312712 Penner Dec 2008 A1
20080312725 Penner Dec 2008 A1
20090036947 Westlund et al. Feb 2009 A1
20090118785 Ignagni et al. May 2009 A1
20100022950 Anderson et al. Jan 2010 A1
20100036451 Hoffer Feb 2010 A1
20100077606 Black et al. Apr 2010 A1
20100094376 Penner Apr 2010 A1
20100114227 Cholette May 2010 A1
20100198296 Ignagni et al. Aug 2010 A1
20100268311 Cardinal et al. Oct 2010 A1
20100319691 Lurie et al. Dec 2010 A1
20110060381 Ignagni et al. Mar 2011 A1
20110077726 Westlund et al. Mar 2011 A1
20110118815 Kuzma et al. May 2011 A1
20110230932 Tehrani et al. Sep 2011 A1
20110288609 Tehrani et al. Nov 2011 A1
20120053654 Tehrani et al. Mar 2012 A1
20120078320 Schotzko et al. Mar 2012 A1
20120158091 Tehrani et al. Jun 2012 A1
20120209284 Westlund et al. Aug 2012 A1
20120215278 Penner Aug 2012 A1
20120323293 Tehrani et al. Dec 2012 A1
20130018247 Glenn et al. Jan 2013 A1
20130018427 Pham et al. Jan 2013 A1
20130023972 Kuzma et al. Jan 2013 A1
20130030496 Karamanoglu et al. Jan 2013 A1
20130030497 Karamanoglu et al. Jan 2013 A1
20130030498 Karamanoglu et al. Jan 2013 A1
20130060245 Grunewald et al. Mar 2013 A1
20130116743 Karamanoglu et al. May 2013 A1
20130131743 Yamasaki et al. May 2013 A1
20130158625 Gelfand et al. Jun 2013 A1
20130165989 Gelfand et al. Jun 2013 A1
20130167372 Black et al. Jul 2013 A1
20130197601 Tehrani et al. Aug 2013 A1
20130289686 Masson et al. Oct 2013 A1
20130296964 Tehrani Nov 2013 A1
20130296973 Tehrani et al. Nov 2013 A1
20130317587 Barker Nov 2013 A1
20130333696 Lee et al. Dec 2013 A1
20140088580 Wittenberger et al. Mar 2014 A1
20140114371 Westlund et al. Apr 2014 A1
20140128953 Zhao et al. May 2014 A1
20140148780 Putz May 2014 A1
20140316486 Zhou et al. Oct 2014 A1
20140324115 Ziegler et al. Oct 2014 A1
20150034081 Tehrani et al. Feb 2015 A1
20150045810 Hoffer et al. Feb 2015 A1
20150045848 Cho et al. Feb 2015 A1
20150119950 Demmer et al. Apr 2015 A1
20150165207 Karamanoglu Jun 2015 A1
20150250982 Osypka Sep 2015 A1
20150265833 Meyyappan et al. Sep 2015 A1
20150374252 De La Rama et al. Dec 2015 A1
Foreign Referenced Citations (20)
Number Date Country
0993840 Apr 2000 EP
1304135 Apr 2003 EP
0605796 Aug 2003 EP
2489395 Aug 2012 EP
2801509 Jun 2001 FR
H08510677 Nov 1996 JP
2003503119 Jan 2003 JP
9407564 Apr 1994 WO
9508357 Mar 1995 WO
9964105 Dec 1999 WO
9965561 Dec 1999 WO
0100273 Jan 2001 WO
02058785 Aug 2002 WO
2006110338 Oct 2006 WO
2006115877 Nov 2006 WO
2007053508 May 2007 WO
2008092246 Aug 2008 WO
2009006337 Jan 2009 WO
2012106533 Aug 2012 WO
2013131187 Sep 2013 WO
Non-Patent Literature Citations (32)
Entry
Amit K. Gupta, “Respiration Rate Measurement Based on Impedance Pneumography”, Texas Instruments, SBAA181—Feb. 2011, 11 pages.
L. Salmela et al., “Verification of the position of a central venous catheter by intra-atrial ECG, When does this method fail?”, Acta Anasthesiol Scand, 1993, vol. 37, Issue 1, pp. 26-28.
Antonica A., et al., “Vagal Control of Lymphocyte Release from Rat Thymus,” Journal of the Autonomic Nervous System, Elsevier, vol. 48(3), Aug. 1994, pp. 187-197.
Whaley K., et al., “C2 Synthesis by Human Monocytes is Modulated by a Nicotinic Cholinergic Receptor,” Nature, vol. 293, Oct. 15, 1981, pp. 580-582 (and reference page).
Borovikovaa L.V., et al., “Role of Vagus Nerve Signaling in CNI-1493-Mediated Suppression of Acute Inflammation,” Autonomic Neuroscience: Basic and Clinical, vol. 85 (1-3), Dec. 20, 2000, pp. 141-147.
Borovikovaa L.V., et al., “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin,” Nature, Macmillan Magazines Ltd, vol. 405, May 25, 2000, pp. 458-462.
Co-pending U.S. Appl. No. 15/606,867, filed May 26, 2017.
Extended European Search Report for Application No. 14864542.7, dated Jun. 2, 2017, 8 pages.
Fleshner M., et al., “Thermogenic and Corticosterone Responses to Intravenous Cytokines (IL-1β and TNF-α) are Attenuated by Subdiaphragmatic Vagotomy,” Journal of Neuroimmunology, vol. 86, Jun. 1998, pp. 134-141.
Gaykema R.P.A. et al., “Subdiaphragmatic Vagotomy Suppresses Endotoxin-Induced Activation of Hypothalamic corticotropin-Releasing Hormone Neurons and Acth Secretion,” Endocrinology, The Endocrine Society, vol. 136 (10), 1995, pp. 4717-4720.
Guslandi M., “Nicotine Treatment for Ulcerative Colitis,” The British Journal of Clinical Pharmacology, Blackwell Science Ltd, vol. 48, 1999, pp. 481-484.
Japanese Office Action in corresponding Japanese Application No. 2014-560202, dated Dec. 6, 2016, 4 pages.
Kawashima K., et al., “Extraneuronal Cholinergic System in Lymphocytes,” Pharmacology & Therapeutics, Elsevier, vol. 86, 2000, pp. 29-48.
Madretsma, G.S., et al., “Nicotine Inhibits the In-vitro Production of Interleukin 2 and Tumour Necrosis Factor-α by Human Mononuclear Cells,” Immunopharmacology, Elsevier, vol. 35 (1), Oct. 1996, pp. 47-51.
Nabutovsky, Y., et al., “Lead Design and Initial Applications of a New Lead for Long-Term Endovascular Vagal Stimulation,” PACE, Blackwell Publishing, Inc, vol. 30(1), Jan. 2007, pp. S215-S218.
Pavlovic D., et al., “Diaphragm Pacing During Prolonged Mechanical Ventilation of the Lungs could Prevent from Respiratory Muscle Fatigue,” Medical Hypotheses, vol. 60 (3), 2003, pp. 398-403.
Planas R.F., et al., “Diaphragmatic Pressures: Transvenous vs. Direct Phrenic Nerve Stimulation,” Journal of Applied Physiology, vol. 59(1), 1985, pp. 269-273.
Romanovsky, A.A., et al., “The Vagus Nerve in the Thermoregulatory Response to Systemic Inflammation,” American Journal of Physiology, vol. 273 (1 Pt 2), 1997, pp. R407-R413.
Sandborn W.J., “Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis,” Annals of Internal Medicine, vol. 126 (5), Mar. 1, 1997, pp. 364-371.
Sato E., et al., “Acetylcholine Stimulates Alveolar Macrophages to Release Inflammatory Cell Chemotactic Activity,” American Journal of Physiology, vol. 274 (Lung Cellular and Molecular Physiology 18), 1998, pp. L970-L979.
Sato, K.Z., et al., “Diversity of mRNA Expression for Muscarinic Acetylcholine Receptor Subtypes and Neuronal Nicotinic Acetylcholine Receptor Subunits in Human Mononuclear Leukocytes and Leukemic Cell Lines,” Neuroscience Letters, vol. 266 (1), 1999, pp. 17-20.
Schauerte P., et al., “Transvenous Parasympathetic Nerve Stimulation in the Inferior Vena Cava and Atrioventricular Conduction,” Journal of Cardiovascular Electrophysiology, vol. 11 (1), Jan. 2000, pp. 64-69.
Schauerte P.N., et al., “Transvenous Parasympathetic Cardiac Nerve Stimulation: An Approach for Stable Sinus Rate Control,” Journal of Cardiovascular Electrophysiology, vol. 10 (11), Nov. 1999, pp. 1517-1524.
Scheinman R.I., et al., “Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids,” Science, vol. 270, Oct. 13, 1995, pp. 283-286.
Sher, M.E. et al., “The Influence of Cigarette Smoking on Cytokine Levels in Patients with Inflammatory Bowel Disease,” Inflammatory Bowel Diseases, vol. 5 (2), May 1999, pp. 73-78.
Steinlein, O., “New Functions for Nicotinic Acetylcholine Receptors?,” Behavioural Brain Research, vol. 95, 1998, pp. 31-35.
Sternberg E.M., (Series Editor) “Neural-Immune Interactions in Health and Disease,” The Journal of Clinical Investigation, vol. 100 (11), Dec. 1997, pp. 2641-2647.
Sykes., A.P., et al., “An Investigation into the Effect and Mechanisms of Action of Nicotine in Inflammatory Bowel Disease,” Inflammation Research, vol. 49, 2000, pp. 311-319.
Toyabe S., et al., “Identification of Nicotinic Acetylcholine Receptors on Lymphocytes in the Periphery as well as Thymus in Mice,” Immunology, vol. 92, 1997, pp. 201-205.
Van Dijk A.P.M., et al., “Transdermal Nicotine Inhibits Interleukin 2 Synthesis by Mononuclear Cells Derived from Healthy Volunteers,” European Journal of Clinical Investigation, vol. 28, 1998, pp. 664-671.
Watkins L.R., et al., “Blockade of Interleukin-1 Induced Hyperthermia by Subdiaphragmatic Vagotomy: Evidence for Vagal Mediation of Immune-Brain Communication,” Neuroscience Letters, vol. 183, 1995, pp. 27-31.
Watkins L.R., et al., “Implications of Immune-to-Brain Communication for Sickness and Pain,” PNAS (Proceedings of the National Academy of Sciences of the USA), vol. 96 (14), Jul. 6, 1999, pp. 7710-7713.
Continuations (1)
Number Date Country
Parent 15666989 Aug 2017 US
Child 15704439 US